- Correction
- Open access
- Published:
Correction: Efficacy and safety of ayurvedic intervention (Sarpgandha Mishran) vs. amlodipine for stage‑i primary hypertension‑ study protocol for a prospective double‑dummy, double‑blind, placebo‑controlled randomized clinical trial
BMC Complementary Medicine and Therapies volume 25, Article number: 183 (2025)
Correction: BMC Complement Med Ther 25, 88 (2025)
Following publication of the original article [1], the author reported that the 13th author was omitted from the author group. Richa Singhal have been added to the author group and are presented correctly in this correction article.
The original article [1] has been corrected.
References
Yadav B, Rao B, Narang R, et al. Efficacy and safety of ayurvedic intervention (Sarpgandha Mishran) vs amlodipine for Stage-I primary hypertension- study protocol for a prospective Double-Dummy, Double-Blind, placebo-controlled randomized clinical trial. BMC Complement Med Ther. 2025;25:88. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12906-025-04802-4.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Yadav, B., Rao, B., Narang, R. et al. Correction: Efficacy and safety of ayurvedic intervention (Sarpgandha Mishran) vs. amlodipine for stage‑i primary hypertension‑ study protocol for a prospective double‑dummy, double‑blind, placebo‑controlled randomized clinical trial. BMC Complement Med Ther 25, 183 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12906-025-04921-y
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12906-025-04921-y